Background: Rubus caesius L. is used in traditional medicine, but pharmacological activity data and standardization methods are lacking. Aims and Objectives: This study sought to conduct a pharmacognostic analysis of R. caesius L. leaves and assess these leaves' hypoglycemic activity. Materials and Methods: External, anatomical, and diagnostic features of the leaves were studied in accordance with the State Pharmacopoeia of the Republic of Belarus T1. Conventional qualitative thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) were used. The hypoglycemic activity of the aqueous extract of the leaves was investigated in an alloxan-induced diabetes model. Results: External, anatomical, and diagnostic features of the leaves were determined. The stomata were anomocytic; calcium oxalate crystals were observed in the mesophyll; stellate-arrayed hairs, star-arrayed hairs, capitate hairs, and simple unicellular hairs with a helical fold were identified. Qualitative results indicated that biologically active substances, such as flavonoids and tannins, were present in R. caesius L. leaves. HPLC and TLC revealed the presence of hyperoside in these leaves. Soundness indicators were defined: The weight loss on drying the R. caesius L. leaves varied from 8.61% to 9.52%, and the average weight loss was 9.1%; determinations of total ash varied from 5.40% to 6.50%; determinations of ash insoluble in hydrochloric acid varied from 0.12% to 0.13%. The hypoglycemic activity of an aqueous extract of R. caesius L. leaves in a 500 mg/kg draught was determined in a rat model of alloxan-induced diabetes. Conclusion: The data obtained here can be used to develop regulatory documentation for a new type of medicinal plant tissue: R. caesius L. leaves.
INTRODUCTION
Medicinal herbal remedies are widely used to treat various pathologies. Plant-based drugs exert fewer negative effects on the body than synthetic drugs; thus, they are better tolerated by patients, have low toxicity, and are significantly less likely to cause adverse allergic reactions. Developing new pharmaceutical drugs, such as ones based on medicinal plants, are a high priority. The Earth's flora is rich and diverse and represents an inexhaustible source of new medicinal plants, many of which are used in traditional medicine and are not officinal. One such plant is Rubus caesius L. in folk medicine, the leaves and fruits of plants of the genus Rubus are used in various treatments. these compounds. It should be noted that both the fruits and other parts of a plant (e.g., the leaves) may contain pharmacologically active compounds. Therefore, utilizing these other constituents of the plant can increase the yield of biologically active compounds. Because the harvested quantity of leaves tends to vary less than that of fruits, the additional utilization of leaves can also result in a more constant supply of raw plant material that is less dependent on seasonal variations. [1, 2, [4] [5] [6] [7] [8] [9] [10] [11] R. caesius L. is a shrub that can reach heights of 50-150 cm. The shoots are usually of two types: Softwood annuals and vegetative woody perennials. The plant blooms from May to August, and the fruit ripens in June-October. Wild forms are widely distributed in Europe, North America, and Asia, where R. caesius L. grows in moist forests, forest ravines, clearings, meadows, and thickets. Bluish blackberry has been cultured in many countries worldwide (e.g., Russia, England, France, Holland, Italy, Japan, the United States, Bulgaria, and others). Gisteva studied the acute toxicity of R. caesius L. and concluded that this crop is safe and non-toxic and can be used in medical treatments. [12, 13] Pharmacognostic studies of the genus Rubus have mainly focused on the fruits. This study aims to investigate the pharmacognostic properties of R. caesius L., which is widely cultured and available in Russia. After characterizing the chemical compounds extracted from the leaves, we investigated whether the extracts exhibited antidiabetic properties in an alloxan-induced diabetes rat model. [1, 4, 7, 8, 10, [14] [15] [16] 
MATERIALS AND METHODS

Experimental
Study of external, anatomical and diagnostic features of R. caesius L. bluish blackberry leaves
The leaves from wild-growing R. caesius L. plants were harvested in late spring and summer of 2012 (MaySeptember) from the Vitebsk region of Belarus. The botanical determination of the leaves was conducted at the Institute of Pharmacognosy of the Medical University of Vitebsk to confirm the identities of the plants. The raw material was dried at room temperature in a well-ventilated area out of direct sunlight using the air shadow method. [2, 3] The anatomical and diagnostic features were examined using a 295 Leica microscope (Germany) with a magnification of ×40/0.65.
When studying the external characteristics, attention was paid to the shape and hairiness of the leaves and the characters of the margins and venation. The length and width of the leaf blade were also measured.
The leaf blade margin and vein (upper and lower sides) were removed and placed in a vial. Then, a 25 g/L solution of sodium hydroxide was added, and the mixture was boiled for 2 min to determine the anatomical and diagnostic features. Then, the contents were poured into a Petri dish. The original liquid was poured out, and the working material was rewetted. The pieces of working material were then placed on a slide in a drop of chloral hydrate, covered with a coverslip, and observed under a Leica 295 microscope (Germany) with a magnification of ×40/0.65. [17] Chemical Characterization
Qualitative chemical analysis
The flavonoid content in the aqueous extract was qualitatively analyzed by complexation with aluminum chloride. Two drops of aluminum chloride were added to 1 mL of the aqueous extract. This solution turned yellow when flavonoids were present. [2, 3, 18] Qualitative determination of biologically active compounds in the bluish blackberry leaves was performed using conventional qualitative reactions, thin-layer chromatography (TLC), and high-performance liquid chromatography (HPLC). [2, 3, 9, 18, 19] TLC About 1 g of crushed R. caesius L. leaves was added to 50 ml of 60% ethanol, and the solution was heated in a steam bath under reflux for 30 min to prepare the test solution. The substance was cooled and filtered through filter paper. The reference solution was prepared by dissolving 0.025 g (accurately weighed) of hyperoside in 96% ethanol.
About 30 µl of the alcoholic extract and 5 µl of the reference solution were added to a TLC system (Merck, Germany) that used cellulose plates as the stationary phase. A solution containing 2-propanolol, anhydrous formic acid, and water (2:5:5) was utilized as the mobile phase. The system was dried for 10 min at 100°C and cooled at room temperature. A solution of 20 g of aluminum chloride in 96% ethanol was sprayed onto the chromatogram. The cellulose plate was then subjected to 365 nm ultraviolet light, and the fluorescence was recorded. [2, 3, 8, 12, 16, 20, 21] 
HPLC
This analysis was performed on an Agilent HP 1100 liquid chromatograph with a G1311A quaternary pump system. This system employs a G1315V column oven and is connected to a G1315V diode-array detector. Data collection and the processing of chromatograms and absorption spectra were performed using the Agilent ChemStation for LC 3D. A Zorbax Eclipse XDS C-18 column 150 mm × 4.6 mm i.d. With a 5 µm particle size (Agilent) was used as the stationary phase. The column was [2, 3, 20, 21] Defining the Purity Indicators
The weight loss upon drying, total ash content, and hydrochloric acid-insoluble ash content were determined using the procedures described in the State Pharmacopoeia of the Republic of Belarus. [2, 3] 
Assessments of the Hypoglycaemic Activity of R. caesis L. Leaves: Laboratory Animals and Treatments
Crushed R. caesius L. leaves were extracted in water according to the Belarus Pharmacopeia to investigate the antidiabetic activity of R. caesius L. leaf extracts in an alloxan-induced diabetes rat model. For this experiment, wild-growing young leaves harvested in Vitebsk from May to September 2012 were infused in pure water at 100°C for 15 min. The infusion was filtered after cooling at room temperature for 45 min. [17] The leaves were then crushed and extracted in water and ethanol. Water extraction was performed by sifting 2.0 g of accurately weighed crushed leaves through a sieve with a pore size of 2 mm. The crushed leaves were stirred in 250 ml of boiling water for 30 min. The liquid was cooled to room temperature and filtered through cotton wool; then, the particles of the raw extract of 1 g of accurately weighed crushed leaves were added to 50 ml of 60% ethanol. The flask was attached to a reflux condenser and heated in a steam bath for 30 min with periodic shaking to wash the raw material particles from the flask walls. The extract was centrifuged for 5 min at 3,000 rpm, and the supernatant was collected. [2, 3] The aqueous extract was then administered to rats daily via intragastric gavage for 10 days. The animals were housed in one-tier cells with a front wire mesh wall and were provided a drinker with fresh, sterilized water. The room temperature was set at 20-22°C, and the humidity was set to F 45-50%. The animals were subjected to natural lighting and all received a standard vivarium diet. [5, 9, 20, 22, 23] To the alloxan-induced diabetes model rats, 1 ml of a 5% alloxan monohydrate solution prepared in citrate buffer, pH 4.5, corresponding to a dose of 125 mg/kg was administered by gavage once at the beginning of the experiment. This compound impairs the β-cells of the pancreatic islets, selectively leading to the development of diabetes. 7 days after the alloxan injection, the different treatment schedules were initiated and continued for 10 days in the control and intervention groups. [20, [22] [23] [24] The rats were separated into four different groups, each consisting of 6 animals. Table 1 presents information on the absence/presence of diabetes and the detailed treatment schedules for the different groups. Treatment was initiated after an induction period, which lasted for 7 days after the alloxan injection. The rats in Group A were housed for the same duration without the administration of alloxan before the placebo treatment began. [22, 23] 
Blood Sampling and Glucose Measurements
Fasting venous blood samples were collected from the tail vein and used to determine the glucose concentrations. The glucose concentrations were measured before beginning the experiment. Only rats with a baseline glucose level of 3.5-6.5 mmol/l were allowed to participate in the study. The rats in Groups B, C, and D were intraperitoneally injected once with 1 ml of a 5% alloxan monohydrate solution, corresponding to a dose of 125 mg/kg. [20, 22, 23] After the 7-day induction period, baseline samples were collected to measure the blood glucose levels immediately before the treatment protocol began. Subsequently, additional measurements were performed after 0, 3, 6 and 10 days of treatment to capture the potential treatment effect. Whole blood was immediately analyzed after drawing being drawn using a Satellite plus portable glucose express meter and test strips (Satellite, Russia). 
Statistical Methods
Qualitative and quantitative descriptions of the data are provided. The glucose concentrations during the treatment phase were compared using the Friedman repeated measures on ranks test. The glucose concentrations among groups with different treatment schemes were compared using the Mann-Whitney U test for comparisons of two groups or the Kruskal-Wallis test for comparisons of three groups. When significant differences were observed among three or more groups, pairwise post-hoc testing was performed via the Conover method. Microsoft Excel (Microsoft, USA) and Medcalc (Medcalc software, Belgium) were employed. P < 0.05 were considered significant.
RESULTS
External Characteristics of R. caesius L. Leaves
The leaves are ternate-compound, and the terminal leaflet is occasionally tripartite. The leaves are greenish-grey, with a slightly white lower surface because of the thin trichomes. The leaves have sparse hair on the top side and unevenly incised-toothed margins; the terminal leaflet is ovate-rhombic on short stalks, and the sides are sessile. The venation consists of a pinnate-net. The leaf length and width are 7.76 ± 1.5 cm and 5.67 ± 2.3 cm, respectively.
Anatomical and Diagnostic Features of Bluish Blackberry Leaves
In the integral raw material, the meandering upper epidermis cells are visible. The stomata are oval and mostly surrounded by 5-6 cell-companions (anomocytic type); many more such structures exist on the lower surface. Numerous hairs are present on both surfaces of the leaves, with more hairs existing on the lower surface. The presence of several types of hair is typical, including simple, singlecelled with a spiral fold, simple capitate hairs, and stararrayed hairs.
Many calcium oxalate druses are present in the leaf mesophyll.
As shown in Figures 1-4 , the basic microscopic diagnostic features of R. caesius L. leaves are the presence of simple single-celled hairs with a spiral fold, star-arrayed hairs, capitate hairs, calcium oxalate crystals in the mesophyll, and anomocytic stomata.
Substance Characterization
The results of the qualitative chemical analysis of the alcoholic and aqueous extracts are shown in Table 2 . Flavonoids and tannins were detected in both extracts. The TLC results of the alcoholic extract are shown in Figure 5 and reveal 6 spots under ultraviolet light. Three spots have kaempferol (isoquercitrin-glycoside). The characterization of spots 2 and 3 can be inferred from literature data, which attribute yellow color and shorter migration to quercetindiglucoside and lemon-yellow color and longer migration to isoquercitrin-glycoside. Isoquercitrin-glycoside exhibits a shorter migration than monosides, such as hyperoside. The other spots are purple (spot 1) and blue (spot 5) and correspond to phenolic acids; no further specification is possible via TLC. [2, 3, 8, 10, 16, 17, 21] 
Identification of Biologically Active Substances in R. caesius L. Leaves using TLC
TLC of an alcoholic extract of R. caesius L. Leaves. A reference solution containing hyperoside (spot 6, yellow) was applied on the right side of the gel, whereas the extract containing spots 1-5 (1 = purple, 2 = yellow, 3 = lemon yellow, 4 = yellow, and 5 = blue) was applied to the left side of the gel. The results are discussed in the text. Spot 6 (yellow) is a standard probe for hyperoside and matches spot 4 in the tested extract.
Identification of Biologically Active Substances in R. caesius L. Leaves using HPLC
Phenolic compounds in R. caesius L. leaves were analyzed by HPLC using a mobile phase consisting of 0.01 M potassium dihydrogen phosphate and acetonitrile (80:20). The peak with a retention time of 9.9 min corresponds to hyperoside.
The chromatogram of the phenolic compounds contained in the R. caesius L. leaves was obtained at 280 nm.
Soundness indicators
The composition of the blue-grey R. caesius L. leaves, as determined using qualitative reactions, is presented in Tables 3-5. As indicated in Table 3 , the weight loss on drying the R. caesius L. leaves varied from 8.61 to 9.52%, and the average weight loss was 9.1%.
Hypoglycemic Activity of R. caesius L. Leaves
The baseline glucose concentrations of the three groups of diabetic rats were not significantly different (P = 0.69). It treatment with the biologically active substances clearly resulted in a highly significant effect on the glucose concentrations in both Groups C and D (P < 0.001). In both groups, this effect was progressive until day 10. Within these groups, post-hoc testing revealed that the differences observed on a specific day were significantly different from those on the other 3 days (P < 0.05). The glucose concentrations did not differ significantly between Groups C and D on days 6 (P = 0.52) and 10 (P = 0.11). However, glibenclamide exerted more prominent and significant treatment effect on day 3 (P = 0.04).
In Groups A, C and D, the animals were calm and exhibited normal urination with no acetone smell. None of the animals died during the experiment. In contrast, the animals in Group B were very active and aggressive and exhibited frequent urination with the smell of acetone.
After observing the experimental animals, the following results were obtained: In Group A, the animals were calm and exhibited normal urination with no smell of acetone and a slight increase in their body weights (5-7 g).
In Group B, the animals were very active and aggressive and exhibited frequent urination with the smell of acetone and a significant decrease in their body weights (20-25 g ).
In Group C, the animals were calm and exhibited normal urination with no smell of acetone and a slight increase in their body weights (5-7 g ).
In Group D, the animals were calm and exhibited normal urination with no smell of acetone and a slight decrease in their body weights (5-7 g).
External diagnostic features of R. caesius L. leaves were established: The leaves are ternate-compound, and the terminal leaflet is occasionally tripartite. The leaves are greenish-gray, and their lower surface is slightly white because of the thin trichomes. The leaves have sparse hairs on the top side and unevenly incised-toothed margins; the terminal leaflet is ovate-rhombic on short stalks, and the sides are sessile. The venation consists of a pinnate-net (Table 6 ).
DISCUSSION
Thus, R. caesius L. leaves may be used as follows: (1) To determine their authenticity and distinguish such leaves from contaminants from other similar plants of the Rubus genus, (2) to develop regulatory documentation for R. caesius L. leaves, a new type of medicinal plant tissue, (3) to treat diabetes and thereby reduce the frequency of synthetic drug use, and (4) to generate substances that may be used to create synthetic drugs and new drugs of plant origin (such as filter bags, granules, and tablets).
Further experiments will focus on determining the optimal dosage, identifying markers for the detection of other biologically active substances in bluish blackberry leaves, and compiling the collection.
To the best of our knowledge, our work is the first to describe a hypoglycemic effect of R. caesius L. extracts on diabetic rats. Similar to the study by Jouad et al. In Rubus fruticosus, we investigated leaf extracts for their potential hypoglycemic activity. Jouad et al. found that extracts of R. fruticosus leaves reduced the glucose levels in normal and diabetic rats. Sharma and Kumar manufactured extracts from Rubus ellipticus fruits and reported significant reductions in the glucose levels of diabetic rats on administration of aqueous solutions of alcohol, water, and petroleum ether extracts. Kanegusuku et al. reported that methanolic extracts of Rubus imperialis exert a hypoglycemic effect on normoglycemic rats. Taken together, these results indicate that Rubus species fruit and leaf extracts exhibit antidiabetic activities. Our findings were somewhat less pronounced. However, they were comparable to the effect exerted by a frequently used antidiabetic agent, glibenclamide. The antidiabetic effect observed here occurred after 6 days of extract administration, and in other studies, this effect became apparent after 3-9 days. Regarding the timing and amount of the decreases, the glucose concentrations observed on the administration of the Rubus species extracts in our study are comparable to those reported in other studies. [11, 24, 25] Other studies proposed mechanisms for the antidiabetic activity exerted by Rubus species extracts. Jouad et al. measured insulin levels on the administration of R. fruticosus extract and showed that insulin secretion was not affected in normal or diabetic mice. Thus, they concluded that at the employed doses, the Rubus species extract exerts its effects via extrapancreatic mechanisms. Investigations of extracts from plants other than Rubus species suggested that hypoglycemic activity may be mediated by the inhibition of corticoid secretion. Our study did not investigate the mechanisms by which the R. caesius L. extract exerted its anti-diabetic effect. Accordingly, we cannot speculate whether the identified substances are responsible. [22, 26, 27] The application of a biologically active substance to an organism always raises the question of toxicity. Gisteva investigated the acute toxicity of R. caesius L. and concluded that this crop is safe and non-toxic class and can be used medicinally. The toxicities of other Rubus species extracts were determined in terms of their LD50 values. In mice receiving an aqueous extract of R. fruticosus L. leaves, the LD50 was 8.1 g/kg body weight, and doses of up to 6 g/kg body weight were well tolerated. Sharma and Kumar observed no behavioral changes or mortality at doses up to an LD50 of 2 g/kg body weight. Our study applied a daily dose of 0.5 g/kg body weight. At this dose, we observed no gross behavioral changes in the investigated rats. This observation is in accord with the results of the toxicity studies by other groups and suggests that R. caesius L. leaves may be safely used at higher doses than those employed in this work, which could increase the treatment effect while minimizing the side effects. [11, 23, 25] There are several limitations of our study. First, we were unable to perform a mass spectrometric analysis to achieve a more precise characterization of the extract components. However, we were able to identify several biologically active compounds that are also found in extracts from other plants. Second, we did not perform a dose-effect escalation in the rat model, instead using only a fixed dose of 0.5 g/kg body weight. We assume that higher doses would not lead to toxicity and may increase the hypoglycemic effect. Third, we did not assess the influence of the harvesting season on the hypoglycemic effects. Kellogg et al. reported the seasonal dependencies of bioactivity in plants in Alaska. The extent to which seasonal variability will modulate the hypoglycemic effects of R. caesius L. leaf extracts was not determined. Finally, whether our findings in this alloxan-induced diabetes rat model can be extrapolated to human beings suffering from diabetes remains unknown. In summary, however, we believe that these limitations do not invalidate our findings. [15, 21, 28] 
CONCLUSION
In conclusion, this study characterized, for the first time, the chemical composition of R. caesius L. leaves. Furthermore, a considerable hypoglycemic effect of the aqueous extract was observed in an established alloxan-induced diabetes rat model. A topic that could be addressed in future research is whether the identified substances are responsible for the observed antidiabetic effect.
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